'Equivocal' antiphospholipid syndrome

Journal of Autoimmunity

Volumn 15, Issue 2, 2000, Pages 81-85

  Harris, E Nigel ^a   Pierangeli, Silvia S ^a  

^a MOREHOUSE SCHOOL OF MEDICINE   (United States)

Author keywords

Anticardiolipin antibodies; Antiphospholipid syndrome; Lupus anticoagulant; Testing for antiphospholipid antibodies

Indexed keywords

BETA2 GLYCOPROTEIN 1; CARDIOLIPIN ANTIBODY; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY;

ANTIPHOSPHOLIPID SYNDROME; CLINICAL FEATURE; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; EVALUATION; HUMAN; IMMUNOASSAY; LABORATORY TEST; LONG TERM CARE; PRIORITY JOURNAL;

EID: 0033830502     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.2000.0419     Document Type: Conference Paper

References (35)

1. Syndrome of the black swan
2. Towards improved criteria for the antiphospholipid syndrome
3. The 'primary' antiphospholipid syndrome: Major clinical and serological features
4. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus: A prospective analysis of 500 consecutive patients
5. The 'catastrophic' antiphospholipid syndrome
6. International consensus statement on preliminary classification for definite antiphospholipid syndrome
7. The second international anticardiolipin standardization workshop/the Kingston Antiphospholipid Antibody Study (KAPS) group
8. Prevalence, significance, and specificity of antibodies to phospholipids in Q fever
9. Anticardiolipin antibodies associated with HTLV-III infection
10. Similarities of specificity and cofactor dependence in serum antiphospholipid antibodies from patients with human parvovirus B19 infection and from those with systemic lupus erythematosus
11. High levels of antiphospholipid antibodies are associated with cytomegalovirus infection in unrelated bone marrow and cord blood allogeneic stem cell transplantation
12. 2-glycoprotein 1 in HIV-sero positive patients: Relationship with endothelial activation and antimalonic dialdehyde antibodies
13. 2-glycoprotein I and anti-prothrombin antibodies in chronic hepatitis C
14. Transverse myelitis: A manifestation of systemic lupus erythematosus with antiphospholipid antibodies: A review of 31 patients
15. A comparison of cardiac valvular involvement in the primary antiphospholipid-anticardiolipoin-negative systemic lupus erythematosus
16. Valvular heart disease in primary antiphospholipid syndrome (PAPS): Clinical and morphological findings
17. Epidemiology of antiphospholipid antibody and vascular disease
18. Anticardiolipin (ACA) antibodies directed not to cardiolipin but to a plasma protein cofactor
19. Anticardiolipin antibodies directed not to cardiolipin but to a plasma protein cofactor
20. 2-glycoprotein I in the absence of phospholipid: Importance of antigen density and bivalent binding
21. A more specific ELISA assay for the detection of antiphospholipid
22. Comparison between the standard anticardiolipin antibody test and a new phospholipid test in patients with a variety of connective tissue diseases
23. 2-glycoprotein 1 antibodies
24. 2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid syndrome: Clinical correlations in comparison with other antibody tests
25. Anti beta glycoprotein 1 antibodies: Detection and association with thrombosis
26. 2-glycoprotein I contribute to a better characterization of the antiphospholipid syndrome
27. 2-glycoprotein I clearly differentiates anticardiolipin antibodies from antiphospholipid syndrome and syphilis
28. Lupus anticoagulant IgG's (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin
29. Mechanism and effects of the binding of lupus anticoagulant IgG and prothrombin to surface phospholipids
30. Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C or protein S: An explanation for their pathogenic mechanism?
31. Anti-annexin V antibody in systemic lupus erythematosus patients with lupus anticoagulant and/or anticardiolipin antibody
32. Accuracy of anticardiolipin antibodies in identifying a history of thrombosis among patients with systemic lupus erythematosus
33. Thrombosis, recurrent fetal loss and thrombocytopenia Predictive value of the anticardiolipin test
34. IgA anticardiolipin antibodies - Relation with other antiphospholipid antibodies and clincial significance
35. Significance of IgA antiphospholipid antibodies